<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01134276</url>
  </required_header>
  <id_info>
    <org_study_id>H-1001-047-307</org_study_id>
    <nct_id>NCT01134276</nct_id>
  </id_info>
  <brief_title>Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers</brief_title>
  <official_title>Prospective Study on the Comparison Between the Clinicopathological Outcomes According to the Methods of Preoperative Biliary Drainage in Periampullary Cancers Causing Obstructive Jaundice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preoperative biliary drainage methods include percutaneous transhepatic biliary drainage
      (PTBD), endoscopic nasobiliary drainage (ENBD), and endoscopic retrograde biliary drainage
      (ERBD). Endoscopic biliary drainages often induce peritumoral inflammation and it increase
      difficulties in determining a proper resection margin. The purpose of this study is to
      compare the clinicopathological outcomes according to the methods of preoperative biliary
      drainage in periampullary cancers causing obstructive jaundice, and to find out a proper
      biliary drainage method.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Infectious Complications After Biliary Drainage</measure>
    <time_frame>within 120 days after drainage</time_frame>
    <description>at least 90 days after operation change in serum bilirubin cholangitis blood test (complete blood cell count, liver function test, CRP)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Total Serum Bilirubin After Drainage</measure>
    <time_frame>within 14 days after drainage</time_frame>
    <description>Effect of reducing serum total bilirubin after drainage in terms of Daily diminution of bilirubin(mg/dL/day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Hospital Cost During Admission After Biliary Drainage</measure>
    <time_frame>during hospital stay for biliary drainage procedure</time_frame>
    <description>Total hospital cost during admission after Biliary Drainage in US dollars</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">211</enrollment>
  <condition>Periampullary Cancers With Obstructive Jaundice</condition>
  <condition>Pancreas Head Cancer</condition>
  <condition>Bile Duct Cancer</condition>
  <condition>Ampulla of Vater Cancer</condition>
  <arm_group>
    <arm_group_label>PTBD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>biliary drainage : PTBD procedure for obstructive jaundice in patients with periampullary cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ERBD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>biliary drainage : ERBD/ENBD procedure for obstructive jaundice in patients with periampullary cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>biliary drainage</intervention_name>
    <description>biliary drainage via PTBD or ERBD/ENBD</description>
    <arm_group_label>PTBD</arm_group_label>
    <arm_group_label>ERBD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient who have periampullary tumors causing obstructive jaundice

          -  patient age: ≥20 and ≤85

          -  resectable state of disease

          -  no history of previous chemotherapy or radiotherapy

          -  patients without uncontrollable severe cardiovascular, respiratory disease

          -  Karnofsky performance scale ≥70

          -  informed consent

        Exclusion Criteria:

          -  patients with distant metastasis or locally advanced disease with major vascular
             invasion

          -  duodenal cancer

          -  biliary drainage before randomization

          -  previous chemotherapy or radiotherapy

          -  uncontrollable active infection except cholangitis

          -  severe comorbid disease (cardiac, pulmonary, cerebrovascular)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Surgery, Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>van der Gaag NA, de Castro SM, Rauws EA, Bruno MJ, van Eijck CH, Kuipers EJ, Gerritsen JJ, Rutten JP, Greve JW, Hesselink EJ, Klinkenbijl JH, Rinkes IH, Boerma D, Bonsing BA, van Laarhoven CJ, Kubben FJ, van der Harst E, Sosef MN, Bosscha K, de Hingh IH, Th de Wit L, van Delden OM, Busch OR, van Gulik TM, Bossuyt PM, Gouma DJ. Preoperative biliary drainage for periampullary tumors causing obstructive jaundice; DRainage vs. (direct) OPeration (DROP-trial). BMC Surg. 2007 Mar 12;7:3.</citation>
    <PMID>17352805</PMID>
  </reference>
  <reference>
    <citation>Speer AG, Cotton PB, Russell RC, Mason RR, Hatfield AR, Leung JW, MacRae KD, Houghton J, Lennon CA. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet. 1987 Jul 11;2(8550):57-62.</citation>
    <PMID>2439854</PMID>
  </reference>
  <reference>
    <citation>Sewnath ME, Karsten TM, Prins MH, Rauws EJ, Obertop H, Gouma DJ. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg. 2002 Jul;236(1):17-27. Review.</citation>
    <PMID>12131081</PMID>
  </reference>
  <reference>
    <citation>Saiki S, Chijiiwa K, Komura M, Yamaguchi K, Kuroki S, Tanaka M. Preoperative internal biliary drainage is superior to external biliary drainage in liver regeneration and function after hepatectomy in obstructive jaundiced rats. Ann Surg. 1999 Nov;230(5):655-62.</citation>
    <PMID>10561089</PMID>
  </reference>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2010</study_first_submitted>
  <study_first_submitted_qc>May 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 31, 2010</study_first_posted>
  <results_first_submitted>April 7, 2014</results_first_submitted>
  <results_first_submitted_qc>June 7, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 11, 2014</results_first_posted>
  <last_update_submitted>June 7, 2014</last_update_submitted>
  <last_update_submitted_qc>June 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Sun-Whe Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bile Duct Neoplasms</mesh_term>
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Jaundice</mesh_term>
    <mesh_term>Jaundice, Obstructive</mesh_term>
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Total 211 patients underwent pancreatoduodenectomy after preoperative biliary drainage at Seoul National University Hospital.</recruitment_details>
      <pre_assignment_details>144 patients and 68 patients were intended to be treated with ERBD/ENBD and PTBD, respectively. Among 144 patients, 39 patients were switched to PTBD due to a procedure failure. Finally, 104 and 107 patients were treated with ERBD/ENBD and PTBD, respectively. Clinical outcomes were compared on the basis on the final drainage method</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>ERBD</title>
          <description>biliary drainage : biliary drainage via ERBD/ENBD</description>
        </group>
        <group group_id="P2">
          <title>PTBD</title>
          <description>biliary drainage : biliary drainage via PTBD</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="104"/>
                <participants group_id="P2" count="107"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="104"/>
                <participants group_id="P2" count="107"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ERBD</title>
          <description>final biliary drainage procedure: biliary drainage via ERBD/ENBD</description>
        </group>
        <group group_id="B2">
          <title>PTBD</title>
          <description>final biliary drainage procedure : biliary drainage via PTBD</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="104"/>
            <count group_id="B2" value="107"/>
            <count group_id="B3" value="211"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.3" spread="8.6"/>
                    <measurement group_id="B2" value="63.5" spread="9.0"/>
                    <measurement group_id="B3" value="64.8" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Korea, Republic of</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104"/>
                    <measurement group_id="B2" value="107"/>
                    <measurement group_id="B3" value="211"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Incidence of Infectious Complications After Biliary Drainage</title>
        <description>at least 90 days after operation change in serum bilirubin cholangitis blood test (complete blood cell count, liver function test, CRP)</description>
        <time_frame>within 120 days after drainage</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PTBD</title>
            <description>finial biliary drainage procedure: biliary drainage via PTBD</description>
          </group>
          <group group_id="O2">
            <title>ERBD</title>
            <description>finial biliary drainage procedure: biliary drainage via ERBD or ENBD</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Infectious Complications After Biliary Drainage</title>
          <description>at least 90 days after operation change in serum bilirubin cholangitis blood test (complete blood cell count, liver function test, CRP)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="107"/>
                <count group_id="O2" value="104"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Total Serum Bilirubin After Drainage</title>
        <description>Effect of reducing serum total bilirubin after drainage in terms of Daily diminution of bilirubin(mg/dL/day)</description>
        <time_frame>within 14 days after drainage</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PTBD</title>
            <description>Final biliary drainage procedure: biliary drainage via PTBD</description>
          </group>
          <group group_id="O2">
            <title>ENBD/ERBD</title>
            <description>Final biliary drainage procedure: biliary drainage via ENBD/ERBD</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Total Serum Bilirubin After Drainage</title>
          <description>Effect of reducing serum total bilirubin after drainage in terms of Daily diminution of bilirubin(mg/dL/day)</description>
          <units>mg/dL/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="107"/>
                <count group_id="O2" value="104"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="0.5"/>
                    <measurement group_id="O2" value="0.6" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Hospital Cost During Admission After Biliary Drainage</title>
        <description>Total hospital cost during admission after Biliary Drainage in US dollars</description>
        <time_frame>during hospital stay for biliary drainage procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PTBD</title>
            <description>Final biliary drainage procedure: biliary drainage via PTBD</description>
          </group>
          <group group_id="O2">
            <title>ERBD</title>
            <description>Final biliary drainage procedure: biliary drainage via ERBD/ENBD</description>
          </group>
        </group_list>
        <measure>
          <title>Total Hospital Cost During Admission After Biliary Drainage</title>
          <description>Total hospital cost during admission after Biliary Drainage in US dollars</description>
          <units>thousands in US dollars</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="107"/>
                <count group_id="O2" value="104"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.0" spread="5.9"/>
                    <measurement group_id="O2" value="17.0" spread="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>7 days after procedure such as PTBD and ENBD/ERBD per Intervention</time_frame>
      <group_list>
        <group group_id="E1">
          <title>PTBD</title>
          <description>final biliary drainage procedure: biliary drainage via PTBD
Adverse event will be monitored by examination of clinic doctor in both in-patient and out-patient setting</description>
        </group>
        <group group_id="E2">
          <title>ERBD</title>
          <description>final biliary drainage procedure: biliary drainage via ERBD/ENBD
Adverse event will be monitored by examination of clinic doctor in both in-patient and out-patient setting</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="107"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="104"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding</sub_title>
                <description>procedure associated bleeding event after PTBD or ENBD/ERBD</description>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="104"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <description>Procedure associated pancreatitis after PTBD and ENBD/ERBD</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="107"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="104"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <description>Procedure associated cholangitis after PTBD and ENBD/ERBD</description>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="104"/>
              </event>
              <event>
                <sub_title>Bile peritonitis</sub_title>
                <description>Procedure associated peritonitis</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="104"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>tube malfunction</sub_title>
                <description>tube malfunction which should be managed with additional procedure after PTBD and ENBD/ERBD</description>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="107"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="104"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="107"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="104"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sun-Whe Kim</name_or_title>
      <organization>Seoul National University College of Medicine</organization>
      <phone>+82-2-2072-2315</phone>
      <email>sunkim@plaza.snu.ac.kr</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

